News

A future in lacrosse was in doubt for River Hill girls lacrosse’s Gabby Bergstrom when she was diagnosed with Guillain-Barré ...
A seasonal flu virus that can lead to paralysis has been detected in California wastewater. Influenza B has been shown at a ...
Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), today announced its interim report for January-March 2025.
SHREVEPORT, La. - In 2011, Shane Sumlin's life changed overnight after being diagnosed with a rare neurological disorder ...
Pune: Residents of several areas in Pimpri Chinchwad have raised concerns over the unclean civic water supply being received ...
A week later, Abraham woke up in the middle of the night and tried to stand. She collapsed to the floor, struggling to ...
This announcement was made alongside the reveal of positive Phase 3 results for Tanruprubart, a monoclonal antibody that can block C1q and can potentially halt neuroinflammation and nerve damage in ...
Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...
The primary endpoint, outcome on the GBS Disability Score (GBS-DS) at 8 weeks, showed 29% of patients treated with tanruprubart at a dose of 30 mg/kg recovered to a healthy state with a score of 0 or ...
A former Beltrami County Jail nurse appeared in court Friday morning for a manslaughter charge stemming from the death of Hardel Sherrell.
As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another effort to improve treatment of the rare condition. | As it advances a ...